FDA orphan drug designation: treatment of gastric cancer, including cancer of the gastroesophageal junction
All entries for: Jiangsu Alphamab Biopharmaceuticals Co. Ltd.
July 27, 2025
Jiangsu Alphamab Biopharmaceuticals Co. Ltd.
Orphan Drug Designation
Disease Area: Rare Diseases